Muscle Ring Finger 1, but not Muscle Ring Finger 2, Regulates Cardiac Hypertrophy In Vivo

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Circulation Research

• Publication date

  2007-03-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.RES.0000259559.48597.32PMID 17272810PMCID PMC4112093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures.

  2006cited by this paper
• CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice.

  2005cited by this paper
• The Kinase Domain of Titin Controls Muscle Gene Expression and Protein Turnover

  2005cited by this paper
• The kinase domain of titin controls muscle gene expression and protein turnover.

  2005cited by this paper
• Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.

  2004cited by this paper
• Muscle ring finger protein-1 inhibits PKCε activation and prevents cardiomyocyte hypertrophy

  2004cited by this paper
• Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I

  2004cited by this paper
• Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload.

  2003cited by this paper
• Use of echocardiography for the phenotypic assessment of genetically altered mice.

  2003cited by this paper
• Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy

  2001cited by this paper

• Mechanically knocking out titin reveals protein tension loss as a trigger of muscle disease

  2025cites this paper
• HCM-Associated MuRF1 Variants Compromise Ubiquitylation and Are Predicted to Alter Protein Structure

  2025influential citation
• The Novel MuRF2 Target SNX5 Regulates PKA Activity Through Stabilization of RI‐α and Controls Myogenic Differentiation

  2025cites this paper
• Uncovering the mechanisms of MuRF1-induced ubiquitylation and revealing similarities with MuRF2 and MuRF3

  2024cites this paper
• Knockout of the Muscle-Specific E3 Ligase MuRF1 Affects Liver Lipid Metabolism upon Dexamethasone Treatment in Mice

  2024cites this paper
• Pharmacologic or genetic interference with atrogene signaling protects against glucocorticoid-induced musculoskeletal and cardiac disease

  2024cites this paper
• Targeting MuRF1 to Combat Skeletal Muscle Wasting in Cardiac Cachexia: Mechanisms and Therapeutic Prospects

  2024cites this paper
• Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies

  2023cites this paper
• ATROPHIC REMODELING OF THE HEART DURING VITAMIN D DEFICIENCY AND INSUFFICIENCY IN A RAT MODEL.

  2023cites this paper
• Identification of hypertrophy-modulating Cullin-RING ubiquitin ligases in primary cardiomyocytes

  2023cites this paper
• The Role of Muscle Ring Finger-1 (MuRF1), MuRF2, MuRF3, and Atrogin-1 on Bone Microarchitecture In Vivo

  2022cites this paper
• Cardiac metabolism in HFpEF: from fuel to signalling.

  2022cites this paper
• The Transcription Factor EB (TFEB) Sensitizes the Heart to Chronic Pressure Overload

  2022cites this paper
• RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1.

  2022cites this paper
• Progress of ubiquitin-proteasome system in the pathophysiology of heart failure and the intervention of traditional Chinese medicine

  2021cites this paper
• PECAM-1 preserves cardiac function in pressure overload-induced biomechanical stress

  2021cites this paper
• Minor hypertrophic cardiomyopathy genes, major insights into the genetics of cardiomyopathies

  2021cites this paper
• TRIM proteins in fibrosis.

  2021cites this paper
• Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway

  2021cites this paper
• MuRF1/TRIM63, Master Regulator of Muscle Mass

  2020influential citation
• The Effect of Different Exercise Intensities on T-Box Transcription Factor 5 Gene Expression and Hypertrophy in the Heart Muscle of Male Rats

  2020cites this paper
• Cellular Protein Quality Control in Diabetic Cardiomyopathy: From Bench to Bedside

  2020cites this paper
• Under construction: The dynamic assembly, maintenance, and degradation of the cardiac sarcomere.

  2020cites this paper
• BK Channel Dysfunction in Diabetic Coronary Artery: Role of the E3 Ubiquitin Ligases

  2020cites this paper
• Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy

  2020cites this paper
• Expression of MuRF1 or MuRF2 is essential for the induction of skeletal muscle atrophy and dysfunction in a murine pulmonary hypertension model

  2020cites this paper
• Emerging Role of TRIM Family Proteins in Cardiovascular Disease

  2020cites this paper
• Zebrafish cysteine and glycine-rich protein 3 is essential for mechanical stability in skeletal muscles.

  2019cites this paper
• Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle–Specific Ubiquitin Ligase MuRF1

  2019cites this paper
• Small‐molecule‐mediated chemical knock‐down of MuRF1/MuRF2 and attenuation of diaphragm dysfunction in chronic heart failure

  2019cites this paper
• Experimental Spinal Cord Injury Causes Left-Ventricular Atrophy and Is Associated with an Upregulation of Proteolytic Pathways

  2019cites this paper
• Proteasome biology and therapeutics in cardiac diseases

  2019cites this paper
• Deleting Full Length Titin Versus the Titin M-Band Region Leads to Differential Mechanosignaling and Cardiac Phenotypes

  2019cites this paper
• Genetic and functional implications of an exonic TRIM55 variant in heart failure.

  2019cites this paper
• Muscle-specific regulation of right ventricular transcriptional responses to chronic hypoxia-induced hypertrophy by the muscle ring finger-1 (MuRF1) ubiquitin ligase in mice

  2018cites this paper
• Inadequate ubiquitination-proteasome coupling contributes to myocardial ischemia-reperfusion injury

  2018cites this paper
• Ubiquitin and Ubiquitin-like proteins in cardiac disease and protection.

  2018cites this paper
• Melatonin and Exercise: Their Effects on Malondialdehyde and Lipid Peroxidation

  2018cites this paper
• Homozygous Nonsense Mutation p.Q274X in TRIM63 (MuRF1) in a Patient with Mild Skeletal Myopathy and Cardiac Hypertrophy

  2018cites this paper
• The E3 ubiquitin ligase MuRF2 attenuates LPS‐induced macrophage activation by inhibiting production of inflammatory cytokines and migration

  2018cites this paper
• The Calcineurin-FoxO-MuRF1 signaling pathway regulates myofibril integrity in cardiomyocytes

  2017cites this paper
• TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels

  2017cites this paper
• WITHDRAWN: The lncRNA-GAS5/miR-23a/Foxo3a axis regulates cardiac hypertrophy by Wnt/β-catenin signal pathway.

  2017cites this paper
• The ubiquitin-proteasome system: A potential therapeutic target for heart failure.

  2017cites this paper
• Ubiquitin Ligases and Posttranslational Regulation of Energy in the Heart: The Hand that Feeds.

  2017cites this paper
• HOTAIR functions as a competing endogenous RNA to regulate PTEN expression by inhibiting miR-19 in cardiac hypertrophy

  2017cites this paper
• Overview of the Muscle Cytoskeleton.

  2017cites this paper
• Protein Degradation in Cardiomyocytes: Target Proteins and Clinical Consequences

  2016cites this paper
• MuRF3 binds to the retromer subunit SNX5 inhibiting its MuRF2-mediated degradation and leading to its stabilization

  2016cites this paper
• Pathophysiology of Heart Failure and an Overview of Therapies

  2016cites this paper
• MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo.

  2016cites this paper
• Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.

  2016cites this paper
• Corticosteroids Are Essential for Maintaining Cardiovascular Function in Male Mice.

  2016cites this paper
• Nebulized Delivery of the MAPKAP Kinase 2 Peptide Inhibitor MMI-0100 Protects Against Ischemia-Induced Systolic Dysfunction

  2016cites this paper
• The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination.

  2015influential citation
• MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet

  2015cites this paper
• levels cause skeletal muscle atrophy via AMPK , FoxO 3 a and muscle-specific ring finger protein 1 ( MuRF 1 )

  2015cites this paper
• Ongoing controversies surrounding cardiac remodeling: is it black and white—or rather fifty shades of gray?

  2015cites this paper
• The Sarcomeric M-Region: A Molecular Command Center for Diverse Cellular Processes

  2015cites this paper
• Platelet Endothelial Cell Adhesion Molecule‐1 Mediates Endothelial‐Cardiomyocyte Communication and Regulates Cardiac Function

  2015cites this paper
• Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet

  2015cites this paper
• Developmental MYH3 Myopathy Associated with Expression of Mutant Protein and Reduced Expression Levels of Embryonic MyHC

  2015cites this paper
• Muscle RING‐finger 2 and 3 maintain striated‐muscle structure and function

  2015cites this paper
• New cardiac and skeletal protein aggregate myopathy associated with combined MuRF1 and MuRF3 mutations.

  2015cites this paper
• Links between mTOR and the immunoproteasome: Therapeutic targets for cardiac hypertrophy?

  2015cites this paper
• High CO2 Levels Cause Skeletal Muscle Atrophy via AMP-activated Kinase (AMPK), FoxO3a Protein, and Muscle-specific Ring Finger Protein 1 (MuRF1)*

  2015cites this paper
• Cardiac Cytoarchitecture

  2015cites this paper
• Cardiac Cytoarchitecture: How to Maintain a Working Heart—Waste Disposal and Recycling in Cardiomyocytes

  2015cites this paper
• Defining the Molecular Mechanisms of Ubiquitin Proteasome System Dysfunction as a Driver of Disease: CHIP mutation in SCAR16

  2015cites this paper
• The E3 ubiquitin ligase Asb2β is downregulated in a mouse model of hypertrophic cardiomyopathy and targets desmin for proteasomal degradation.

  2015cites this paper
• Muscle RING Finger-1 Promotes a Maladaptive Phenotype in Chronic Hypoxia-Induced Right Ventricular Remodeling

  2014cites this paper
• The Pathophysiology of Cardiac Hypertrophy and Heart Failure

  2014cites this paper
• MicroRNAs in heart failure: Small molecules with major impact

  2014cites this paper
• Cardiac Muscle RING Finger 1 Inhibits Adaptive Hypertrophic Remodeling Induced by IGF-1, Exercise, and Thyroid Hormone

  2014cites this paper
• Noninvasive Imaging of In Vivo MuRF1 Expression during Muscle Atrophy

  2014cites this paper
• Regulation of Large Conductance Ca2+-activated K+ (BK) Channel β1 Subunit Expression by Muscle RING Finger Protein 1 in Diabetic Vessels*

  2014cites this paper
• MicroRNA Regulation and Cardiac Calcium Signaling: Role in Cardiac Disease and Therapeutic Potential

  2014cites this paper
• Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1‐mediated gene expression in vivo

  2014influential citation
• MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.

  2014cites this paper
• H2O2 Induces Myocardial Hypertrophy in H9c2 Cells: A Potential Role of Ube3a

  2014cites this paper
• Minireview: hey U(PS): metabolic and proteolytic homeostasis linked via AMPK and the ubiquitin proteasome system.

  2014cites this paper
• Rare Variants in Genes Encoding MuRF1 and MuRF2 Are Modifiers of Hypertrophic Cardiomyopathy

  2014cites this paper
• Targeting the Ubiquitin-Proteasome System in Heart Disease: The Basis for New Therapeutic Strategies

  2014cites this paper
• Gigantic Business: Titin Properties and Function Through Thick and Thin

  2014cites this paper
• The role of ubiquitin ligases in cardiac disease.

  2014cites this paper
• Non-targeted metabolomics analysis of cardiac Muscle Ring Finger-1 (MuRF1), MuRF2, and MuRF3 in vivo reveals novel and redundant metabolic changes

  2014cites this paper
• Natural Aminoacyl tRNA Synthetase Fragment Enhances Cardiac Function after Myocardial Infarction

  2014cites this paper
• MicroRNA as biomarkers and regulator of cardiovascular development and disease.

  2014cites this paper
• Does p.Q247X in TRIM63 Cause Human Hypertrophic Cardiomyopathy?

  2014cites this paper
• Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

  2014cites this paper
• Muscle Atrophy in Response to Cytotoxic Chemotherapy Is Dependent on Intact Glucocorticoid Signaling in Skeletal Muscle

  2014cites this paper
• Muscle-Specific RING Finger 1 Negatively Regulates Pathological Cardiac Hypertrophy Through Downregulation of Calcineurin A

  2014cites this paper
• The Role of AMPK in the Control of Cardiac Hypertrophy

  2014cites this paper
• Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling.

  2014cites this paper
• MuRF1 activity is present in cardiac mitochondria and regulates reactive oxygen species production in vivo

  2014cites this paper
• The ubiquitin proteasome system in human cardiomyopathies and heart failure.

  2013cites this paper
• The AKT/FOXO3A/Atrogin - 1 signaling pathways underlying cardiac regression after detraining in a mouse heart

  2013cites this paper
• Breaking down protein degradation mechanisms in cardiac muscle.

  2013cites this paper
• Correction: Cardio-Metabolic Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir)

  2013cites this paper
• Carboxyl terminus of Hsp70‐interacting protein (CHIP) is required to modulate cardiac hypertrophy and attenuate autophagy during exercise

  2013cites this paper